Percutaneous microwave ablation versus surgical resection for ovarian cancer liver metastasis
Shuiqing Zhuo, Jian Zhou, Guangying Ruan and 4 more
International Journal of Hyperthermia · 2020
doi:10.1080/02656736.2019.1706767 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Objective To compare the oncological outcomes between microwave ablation (MWA) and surgical resection (SR) in patients with ovarian cancer liver metastasis (OCLM). Materials and methods In this retrospective study, a total of 29 female patients (mean age, 47.8 ± 12.9 years; range, 21–65 years) diagnosed with forty-three OCLM nodules between September 2008 and July 2016 were included. All patients with ovarian cancer received chemotherapy and cytoreductive surgery (CRS). Fifteen patients with 22 nodules underwent MWA, and 14 patients with 21 nodules underwent SR. Overall survival (OS), local tumor recurrence-free survival (LTRS), and operation-related parameters were compared between the two groups. Multivariate analyses were performed on clinicopathological variables to identify factors affecting OS and LTRS. Results The median follow-up time was 70.2 months (range, 12.1–107.2 months). Fourteen patients died during this period. The 1-, 3-, and 5-year OS and LTRS rates after MWA were comparable to those after SR (p =.198 and p =.889, respectively). Compared with the SR group, the MWA group had a shorter surgical time (p <.001), less estimated blood loss (p <.001), shorter postoperative hospitalization (p <.001) and fewer costs (p =.015). The multivariate analysis showed that old age (p =.001) was a predictor of poor OS and that intrahepatic tumor size (p =.005) and intrahepatic tumor number (p =.001) were predictors of poor LTRS. Conclusion Percutaneous MWA had comparable oncologic outcomes with those of SR and could be a safe and effective treatment for OCLM.
Abstract licence: CC BY-NC
References29
- 26.
28 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.